CLINICAL_TRIALS
trial_result
· 2025-12-26
Clinical Trial Update: Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients [Phase 1, Phase 2]
Summary
The Phase 1/2 clinical study of CWP232291 in Acute Myeloid Leukemia has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: JW Pharmaceutical | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: TERMINATED